Coronary Artery Disease
Conditions
Brief summary
Can Ayurvedic therapy improve markers of cardiovascular health and cardiovascular risk factors in patients with coronary artery disease.
Detailed description
Patients with established coronary artery disease will be treated with 90 days of Ayurvedic therapy to include yoga, meditation, breathing exercises,and herbs. Arterial stiffness, weight, BMI, BP, medications, cholesterol, LDL, HDL, triglyceride, HS-CRP will be measured at baseline and after 90 days of therapy.
Interventions
OTHERAyurveda
Ayurveda includes meditation, yoga, breathing exercises, herbs
Sponsors
University of New Mexico
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
* stable coronary artery disease (prior mi, coronary angioplasty or stent, coronary bypass surgery)
Exclusion criteria
* age \< 18 years * life expectancy \< 6 months * pregnancy or breast feeding * unwilling or unable to complete 90 days of therapy * already receiving/taking Ayurvedic therapy * unable to converse in or understand English language
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Participants With Arterial Stiffness Were Measured as Pulse Wave Velocity Meters/Second | 3 months |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Ayurveda Ayurvedic therapy
Ayurveda: Ayurveda includes meditation, yoga, breathing exercises, herbs | 22 |
| Total | 22 |
Baseline characteristics
| Characteristic | Ayurveda | — |
|---|---|---|
| Age, Categorical <=18 years | 0 Participants | — |
| Age, Categorical >=65 years | 0 Participants | — |
| Age, Categorical Between 18 and 65 years | 22 Participants | — |
| Race and Ethnicity Not Collected | — | — Participants |
| Region of Enrollment United States | 22 Participants | — |
| Sex: Female, Male Female | NA Participants | — |
| Sex: Female, Male Male | NA Participants | — |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | 0 / 19 |
| other Total, other adverse events | 0 / 19 |
| serious Total, serious adverse events | 0 / 19 |
Outcome results
Primary
Participants With Arterial Stiffness Were Measured as Pulse Wave Velocity Meters/Second
Time frame: 3 months
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Ayurveda | Participants With Arterial Stiffness Were Measured as Pulse Wave Velocity Meters/Second | 19 Participants |